<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04045626</url>
  </required_header>
  <id_info>
    <org_study_id>N28</org_study_id>
    <nct_id>NCT04045626</nct_id>
  </id_info>
  <brief_title>Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns</brief_title>
  <official_title>Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess depth of demarcation line in transepithelial versus epithelium-off accelerated
      cross-linking in keratoconus patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anterior segment optical coherence tomography &quot;OCT&quot; will be performed to evaluate the corneal
      stroma for the presence of demarcation line 1 month postoperatively by an independent
      observer unware of purpose of study
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>evaluation of depth of demarcation line</measure>
    <time_frame>1 month postoperative</time_frame>
    <description>Anterior segment optical coherence tomography &quot;AS-OCT&quot; is used to measure depth of demarcation line</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Progressive Keratoconus</condition>
  <arm_group>
    <arm_group_label>Transepithelial accelerated cross-linking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracel is instilled 1 drop every 1.5 minutes for 4.5 minutes then vibex-xtra is instilled 4 drops at 5.5 minutes followed by 1 drop at 6.5 minutes for a total soak time of 11 minutes followed by ultraviolet-A&quot; UVA&quot; irradiation with intended irradiance of 45mW/cm2 for 2.4 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epithelium-off accelerated cross-linking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vibex-rapid is instilled every 2 minutes for 10 minutes followed by ultraviolet-A &quot;UVA&quot; irradiation of 30 mW/cm2 for 4 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>corneal cross-linking</intervention_name>
    <description>Riboflavin is instilled over cornea followed by Ultraviolet-A irradiation</description>
    <arm_group_label>Epithelium-off accelerated cross-linking</arm_group_label>
    <arm_group_label>Transepithelial accelerated cross-linking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  progressive keratoconus stage 1-2

        Exclusion Criteria:

          -  any concomitant ocular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Azzam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kasr Al Ainy, cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Azzam, MD</last_name>
    <phone>+201227425601</phone>
    <email>sarahazzam@ymail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kasr Al Ainy teaching hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Azzam, MD</last_name>
      <phone>+01227425601</phone>
      <email>sarahazzam@ymail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2019</study_first_posted>
  <last_update_submitted>August 3, 2019</last_update_submitted>
  <last_update_submitted_qc>August 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Sarah Akram Azzam</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

